These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 33217815)
21. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer. Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y PeerJ; 2024; 12():e17130. PubMed ID: 38515458 [TBL] [Abstract][Full Text] [Related]
22. Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma. Zhu Y; Yang W; Ji G; Lin N; Wu W; Xiong P; Zheng C; Yan L; Wan P; Wang Y Oncotarget; 2017 May; 8(19):31092-31100. PubMed ID: 28415703 [TBL] [Abstract][Full Text] [Related]
23. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer. Deng H; Li T; Wei F; Han W; Xu X; Zhang Y Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965 [No Abstract] [Full Text] [Related]
24. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. Zhang Q; Xia T; Qi C; Du J; Ye C BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454 [TBL] [Abstract][Full Text] [Related]
25. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related]
26. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC. Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555 [TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. Huo J; Wu L; Zang Y J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851 [TBL] [Abstract][Full Text] [Related]
28. Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data. Zhang X; Zhan D; Li Y; Wang H; Cheng C; Yao Y; Jia J Med Sci Monit; 2020 May; 26():e921775. PubMed ID: 32392186 [TBL] [Abstract][Full Text] [Related]
29. Pan-cancer analysis of TMEM45A and exploration of its prognostic value and mechanism in gastric cancer. Xie Q; Guo T; Deng H; Yu C; Fang C Cell Mol Biol (Noisy-le-grand); 2024 Jul; 70(7):218-229. PubMed ID: 39097870 [TBL] [Abstract][Full Text] [Related]
30. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics. Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777 [TBL] [Abstract][Full Text] [Related]
31. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer. Xie JF; Xie NS; Tang JH; Gu QP; Luo QT Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424 [TBL] [Abstract][Full Text] [Related]
32. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
33. Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA. Cai C; Yang L; Tang Y; Wang H; He Y; Jiang H; Zhou K DNA Cell Biol; 2019 Sep; 38(9):1005-1012. PubMed ID: 31335180 [TBL] [Abstract][Full Text] [Related]
34. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis. Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079 [No Abstract] [Full Text] [Related]
35. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools. Liu J; Liu Z; Zhang X; Gong T; Yao D BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865 [TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer. Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837 [TBL] [Abstract][Full Text] [Related]
37. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer. Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164 [TBL] [Abstract][Full Text] [Related]
38. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis. Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295 [TBL] [Abstract][Full Text] [Related]
39. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer. Zhang J; Dai WJ; Yang XZ Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737 [TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer. Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]